US Stock MarketDetailed Quotes

CGON CG Oncology

Watchlist
  • 35.910
  • +0.380+1.07%
Close Nov 1 16:00 ET
  • 35.910
  • 0.0000.00%
Post 16:20 ET
2.41BMarket Cap-31555P/E (TTM)

CG Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-49.45%-16.12M
-225.72%-26.01M
-53.26%-45.68M
-135.19%-16.06M
-10.85M
-10.79M
-7.99M
-118.28%-29.8M
-6.83M
-13.65M
Net income from continuing operations
-62.73%-18.9M
-95.36%-16.93M
-37.14%-48.61M
-92.04%-16.12M
---12.21M
---11.62M
---8.67M
-176.06%-35.44M
---8.39M
---12.84M
Operating gains losses
----
----
----
----
----
----
----
----
----
---372K
Depreciation and amortization
75.00%7K
0.00%4K
13.33%17K
0.00%4K
--5K
--4K
--4K
50.00%15K
--4K
--10K
Other non cash items
-101.61%-10K
-102.40%-3K
60.90%819K
-113.08%-14K
--87K
--621K
--125K
26.62%509K
--107K
--402K
Change In working capital
951.40%3.01M
-2,351.74%-8.4M
-22.53%3.44M
65.80%2.16M
--618K
--286K
--373K
325.67%4.44M
--1.3M
---1.97M
-Change in prepaid assets
327.87%1.21M
-2,624.11%-5.65M
-353.77%-2.72M
-168.92%-490K
---1.93M
---531K
--224K
153.76%1.07M
--711K
---2M
-Change in payables and accrued expense
131.09%1.89M
-1,920.13%-2.71M
85.55%6.15M
347.22%2.65M
--2.53M
--817K
--149K
2,807.02%3.31M
--593K
--114K
-Change in other current assets
---1K
---33K
-75.00%13K
--0
--13K
--0
--0
161.18%52K
--0
---85K
Cash from discontinued investing activities
Operating cash flow
-49.45%-16.12M
-225.72%-26.01M
-53.26%-45.68M
-135.19%-16.06M
---10.85M
---10.79M
---7.99M
-118.28%-29.8M
---6.83M
---13.65M
Investing cash flow
Cash flow from continuing investing activities
-135.05%-36.23M
-290.66%-307.44M
-118.95%-121.2M
130.62%16.94M
-162.8M
103.36M
-78.7M
-56,963.92%-55.35M
-55.34M
-97K
Net PPE purchase and sale
-133.33%-14K
---12K
--0
--0
--6K
---6K
--0
85.57%-14K
--1K
---97K
Net investment purchase and sale
-135.04%-36.22M
-290.64%-307.43M
-119.01%-121.2M
130.62%16.94M
---162.8M
--103.36M
---78.7M
---55.34M
---55.34M
--0
Cash from discontinued investing activities
Investing cash flow
-135.05%-36.23M
-290.66%-307.44M
-118.95%-121.2M
130.62%16.94M
---162.8M
--103.36M
---78.7M
-56,963.92%-55.35M
---55.34M
---97K
Financing cash flow
Cash flow from continuing financing activities
100.26%40K
52,735.03%402.66M
-27.32%87M
-105.10%-2.89M
105.88M
-15.23M
-765K
674.91%119.69M
56.7M
15.45M
Net issuance payments of debt
--0
56.18%-365K
---16.29M
---1K
---67K
---15.39M
---833K
--0
--0
--15.2M
Net common stock issuance
--0
--406.41M
----
----
----
--0
--0
----
----
----
Net preferred stock issuance
----
----
-12.47%104.63M
-100.00%2K
----
----
----
--119.53M
--56.55M
--0
Proceeds from stock option exercised by employees
-53.33%77K
--0
1,154.22%2.08M
76.35%261K
--1.59M
--165K
--68K
-32.24%166K
--148K
--245K
Net other financing activities
---37K
---3.39M
---3.42M
---3.15M
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
100.26%40K
52,735.03%402.66M
-27.32%87M
-105.10%-2.89M
--105.88M
---15.23M
---765K
674.91%119.69M
--56.7M
--15.45M
Net cash flow
Beginning cash position
11,078.64%77.47M
-90.62%8.27M
64.42%88.14M
-89.03%10.27M
--78.04M
--693K
--88.14M
3.27%53.61M
--93.61M
--51.91M
Current changes in cash
-167.63%-52.31M
179.13%69.2M
-331.29%-79.88M
63.30%-2.01M
---67.77M
--77.35M
---87.45M
1,937.52%34.54M
---5.47M
--1.7M
End cash Position
-67.76%25.16M
11,078.64%77.47M
-90.62%8.27M
-90.62%8.27M
--10.27M
--78.04M
--693K
64.42%88.14M
--88.14M
--53.61M
Free cash flow
-49.50%-16.13M
-225.87%-26.02M
-53.19%-45.68M
-135.22%-16.06M
---10.84M
---10.79M
---7.99M
-116.84%-29.82M
---6.83M
---13.75M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -49.45%-16.12M-225.72%-26.01M-53.26%-45.68M-135.19%-16.06M-10.85M-10.79M-7.99M-118.28%-29.8M-6.83M-13.65M
Net income from continuing operations -62.73%-18.9M-95.36%-16.93M-37.14%-48.61M-92.04%-16.12M---12.21M---11.62M---8.67M-176.06%-35.44M---8.39M---12.84M
Operating gains losses ---------------------------------------372K
Depreciation and amortization 75.00%7K0.00%4K13.33%17K0.00%4K--5K--4K--4K50.00%15K--4K--10K
Other non cash items -101.61%-10K-102.40%-3K60.90%819K-113.08%-14K--87K--621K--125K26.62%509K--107K--402K
Change In working capital 951.40%3.01M-2,351.74%-8.4M-22.53%3.44M65.80%2.16M--618K--286K--373K325.67%4.44M--1.3M---1.97M
-Change in prepaid assets 327.87%1.21M-2,624.11%-5.65M-353.77%-2.72M-168.92%-490K---1.93M---531K--224K153.76%1.07M--711K---2M
-Change in payables and accrued expense 131.09%1.89M-1,920.13%-2.71M85.55%6.15M347.22%2.65M--2.53M--817K--149K2,807.02%3.31M--593K--114K
-Change in other current assets ---1K---33K-75.00%13K--0--13K--0--0161.18%52K--0---85K
Cash from discontinued investing activities
Operating cash flow -49.45%-16.12M-225.72%-26.01M-53.26%-45.68M-135.19%-16.06M---10.85M---10.79M---7.99M-118.28%-29.8M---6.83M---13.65M
Investing cash flow
Cash flow from continuing investing activities -135.05%-36.23M-290.66%-307.44M-118.95%-121.2M130.62%16.94M-162.8M103.36M-78.7M-56,963.92%-55.35M-55.34M-97K
Net PPE purchase and sale -133.33%-14K---12K--0--0--6K---6K--085.57%-14K--1K---97K
Net investment purchase and sale -135.04%-36.22M-290.64%-307.43M-119.01%-121.2M130.62%16.94M---162.8M--103.36M---78.7M---55.34M---55.34M--0
Cash from discontinued investing activities
Investing cash flow -135.05%-36.23M-290.66%-307.44M-118.95%-121.2M130.62%16.94M---162.8M--103.36M---78.7M-56,963.92%-55.35M---55.34M---97K
Financing cash flow
Cash flow from continuing financing activities 100.26%40K52,735.03%402.66M-27.32%87M-105.10%-2.89M105.88M-15.23M-765K674.91%119.69M56.7M15.45M
Net issuance payments of debt --056.18%-365K---16.29M---1K---67K---15.39M---833K--0--0--15.2M
Net common stock issuance --0--406.41M--------------0--0------------
Net preferred stock issuance ---------12.47%104.63M-100.00%2K--------------119.53M--56.55M--0
Proceeds from stock option exercised by employees -53.33%77K--01,154.22%2.08M76.35%261K--1.59M--165K--68K-32.24%166K--148K--245K
Net other financing activities ---37K---3.39M---3.42M---3.15M------------------------
Cash from discontinued financing activities
Financing cash flow 100.26%40K52,735.03%402.66M-27.32%87M-105.10%-2.89M--105.88M---15.23M---765K674.91%119.69M--56.7M--15.45M
Net cash flow
Beginning cash position 11,078.64%77.47M-90.62%8.27M64.42%88.14M-89.03%10.27M--78.04M--693K--88.14M3.27%53.61M--93.61M--51.91M
Current changes in cash -167.63%-52.31M179.13%69.2M-331.29%-79.88M63.30%-2.01M---67.77M--77.35M---87.45M1,937.52%34.54M---5.47M--1.7M
End cash Position -67.76%25.16M11,078.64%77.47M-90.62%8.27M-90.62%8.27M--10.27M--78.04M--693K64.42%88.14M--88.14M--53.61M
Free cash flow -49.50%-16.13M-225.87%-26.02M-53.19%-45.68M-135.22%-16.06M---10.84M---10.79M---7.99M-116.84%-29.82M---6.83M---13.75M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data